Morphological and functional differentiation in BE(2)-M17 human neuroblastoma cells by treatment with Trans-retinoic acid

BMC Neuroscience

Volumn 14, Issue , 2013, Pages

  Andres, Devon ^a   Keyser, Brian M ^a   Petrali, John ^a   Benton, Betty ^a   Hubbard, Kyle S ^a   McNutt, Patrick M ^a   Ray, Radharaman ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Cell maturation; Differentiation; M17; Neuroexocytosis; Neurons; Neurotoxicity; Retinoic acid; Voltage gated calcium channels

Indexed keywords

BUNGAROTOXIN RECEPTOR; CALCIUM; NEURON SPECIFIC ENOLASE; PHOSGENE; RETINOIC ACID; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; VOLTAGE GATED CALCIUM CHANNEL;

ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DEPOLARIZATION; DISEASE MARKER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MICROSCOPY; NEURITE; NEUROBLASTOMA CELL; NEUROTOXICITY; NEUROTRANSMISSION; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CALCIMYCIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CALCIUM IONOPHORES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SIZE; CHEMICAL WARFARE AGENTS; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION; GLYCINE; HUMANS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEUROTRANSMITTER AGENTS; PHOSGENE; POTASSIUM CHLORIDE; RECEPTORS, CHOLINERGIC; SYNAPSES; SYNAPSINS; TRETINOIN; TRITIUM; TUBULIN;

EID: 84876178566     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-14-49     Document Type: Article

References (40)

1. Harry GJ, Billingsley M, Bruinink A, Campbell IL, Classen W, Dorman DC, Galli C, Ray D, Smith RA, Tilson HA. In vitro techniques for the assessment of neurotoxicity. Environ Health Perspect 1998, 106(Suppl 1):131-158. 10.1289/ehp.98106s1131, 1533280, 9539010.
2. Radio NM, Mundy WR. Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 2008, 29(3):361-376. 10.1016/j.neuro.2008.02.011, 18403021.
3. Tiffany-Castiglioni E, Ehrich M, Dees L, Costa LG, Kodavanti PR, Lasley SM, Oortgiesen M, Durham HD. Bridging the gap between in vitro and in vivo models for neurotoxicology. Toxicol Sci 1999, 51(2):178-183. 10.1093/toxsci/51.2.178, 10543019.
4. Tiffany-Castiglioni E, Hong S, Qian Y, Tang Y, Donnelly KC. In vitro models for assessing neurotoxicity of mixtures. Neurotoxicology 2006, 27(5):835-839. 10.1016/j.neuro.2006.05.010, 16843529.
5. Cho T, Tiffany-Castiglioni E. Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells. J Toxicol Environ Health A 2004, 67(13):987-1000. 10.1080/15287390490447287, 15205030.
6. Ray J, Peterson DA, Schinstine M, Gage FH. Proliferation, differentiation, and long-term culture of primary hippocampal neurons. Proc Natl Acad Sci U S A 1993, 90(8):3602-3606. 10.1073/pnas.90.8.3602, 46349, 8475109.
7. Costa LG. Neurotoxicity testing: a discussion of in vitro alternatives. Environ Health Perspect 1998, 106(Suppl 2):505-510. 10.1289/ehp.98106505, 1533418, 9599699.
8. Gartlon J, Kinsner A, Bal-Price A, Coecke S, Clothier RH. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicol In Vitro 2006, 20(8):1569-1581. 10.1016/j.tiv.2006.07.009, 16959468.
9. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, Cheung NK, Ross RA. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004, 6(6):838-845. 10.1593/neo.04310, 1531688, 15720811.
10. Messi E, Florian MC, Caccia C, Zanisi M, Maggi R. Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression. BMC Cancer 2008, 8:30. 10.1186/1471-2407-8-30, 2254429, 18230156.
11. Ross RA, Biedler JL, Spengler BA. A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett 2003, 197(1-2):35-39.
12. Bjarnadottir M, Misner DL, Haverfield-Gross S, Bruun S, Helgason VG, Stefansson H, Sigmundsson A, Firth DR, Nielsen B, Stefansdottir R. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J Neurosci 2007, 27(17):4519-4529. 10.1523/JNEUROSCI.4314-06.2007, 17460065.
13. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973, 33(11):2643-2652.
14. Melino G, Thiele CJ, Knight RA, Piacentini M. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol 1997, 31(1-2):65-83.
15. Keller JE, Neale EA. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A. J Biol Chem 2001, 276(16):13476-13482. 10.1074/jbc.M010992200, 11278807.
16. Sheridan RE, Smith TJ, Adler M. Primary cell culture for evaluation of botulinum neurotoxin antagonists. Toxicon 2005, 45(3):377-382. 10.1016/j.toxicon.2004.11.009, 15683877.
17. Ray R, Zhang P, Ray P. Neuronal functions associated with endo- and exocytotic events-cum-molecular trafficking may be cell maturation-dependent: lessons learned from studies on botulism. Cell Mol Neurobiol 2011, 31(6):861-865. 10.1007/s10571-011-9678-1, 21625961.
18. Bigalke H, Heller I, Bizzini B, Habermann E. Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch Pharmacol 1981, 316(3):244-251. 10.1007/BF00505657, 6114440.
19. Anand A, Paintal AS, Whitteridge D. Mechanisms underlying enhanced responses of J receptors of cats to excitants in pulmonary oedema. J Physiol 1993, 471:535-547. 1143975, 8120820.
20. Sciuto AM, Lee RB, Forster JS, Cascio MB, Clapp DL, Moran TS. Temporal changes in respiratory dynamics in mice exposed to phosgene. Inhal Toxicol 2002, 14(5):487-501. 10.1080/089583701753678580, 12028804.
21. Ray P, Millard CB, Petrali JP, Berman JD, Ray R. Acetylcholine exocytosis in PC12 cells deficient in SNAP-25. Neuroreport 1997, 8(9-10):2271-2274.
22. Williamson LC, Halpern JL, Montecucco C, Brown JE, Neale EA. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J Biol Chem 1996, 271(13):7694-7699. 10.1074/jbc.271.13.7694, 8631808.
23. Aufderheide M. Direct exposure methods for testing native atmospheres. Exp Toxicol Pathol 2005, 57(Suppl 1):213-226.
24. Aufderheide M, Knebel JW, Ritter D. A method for the in vitro exposure of human cells to environmental and complex gaseous mixtures: application to various types of atmosphere. Altern Lab Anim 2002, 30(4):433-441.
25. Aufderheide M, Knebel JW, Ritter D. An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Exp Toxicol Pathol 2003, 55(1):51-57. 10.1078/0940-2993-00298, 12940629.
26. Aufderheide M, Knebel JW, Ritter D. Novel approaches for studying pulmonary toxicity in vitro. Toxicol Lett 2003, 140-141:205-211.
27. Aufderheide M, Mohr U. CULTEX-an alternative technique for cultivation and exposure of cells of the respiratory tract to airborne pollutants at the air/liquid interface. Exp Toxicol Pathol 2000, 52(3):265-270. 10.1016/S0940-2993(00)80044-5, 10930128.
28. Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 1993, 53(20):4978-4986.
29. Herrero CJ, Garcia-Palomero E, Pintado AJ, Garcia AG, Montiel C. Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem. Br J Pharmacol 1999, 127(6):1375-1387. 10.1038/sj.bjp.0702692, 1760671, 10455287.
30. Huang L, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H, Zhang M, Ragsdale DS, Li M. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluo ro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 2004, 309(1):193-199. 10.1124/jpet.103.060814, 14718587.
31. Turner TJ, Adams ME, Dunlap K. Calcium channels coupled to glutamate release identified by omega-Aga-IVA. Science 1992, 258(5080):310-313. 10.1126/science.1357749, 1357749.
32. Varga BV, Hadinger N, Gocza E, Dulberg V, Demeter K, Madarasz E, Herberth B. Generation of diverse neuronal subtypes in cloned populations of stem-like cells. BMC Dev Biol 2008, 8:89. 10.1186/1471-213X-8-89, 2556672, 18808670.
33. Abemayor E, Sidell N. Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ Health Perspect 1989, 80:3-15. 1567609, 2538324.
34. Shaw G. Neurofilament proteins. The Neuronal Cytoskeleton 1991, 195-214. New York: Wiley-Liss, Burgoyne R.
35. Chin LS, Li L, Ferreira A, Kosik KS, Greengard P. Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice. Proc Natl Acad Sci U S A 1995, 92(20):9230-9234. 10.1073/pnas.92.20.9230, 40958, 7568107.
36. Tojima T, Akiyama H, Itofusa R, Li Y, Katayama H, Miyawaki A, Kamiguchi H. Attractive axon guidance involves asymmetric membrane transport and exocytosis in the growth cone. Nat Neurosci 2007, 10(1):58-66. 10.1038/nn1814, 17159991.
37. Blankenship J. Neurophysiology 2003, St Louis: Mosby.
38. Squire LR BF, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ. Fundamental neuroscience 2003, Amsterdam: Academic Press, 2.
39. Turner CP, Connell J, Blackstone K, Ringler SL. Loss of calcium and increased apoptosis within the same neuron. Brain Res 2007, 1128(1):50-60. 1876679, 17125751.
40. Turner CP, Pulciani D, Rivkees SA. Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol 2002, 178(1):21-32. 10.1006/exnr.2002.8027, 12460605.